Angle PLC - liquid biopsy company - Confirms that it has completed the work required to answer questions raised by US Food & Drug Administration in its additional information request and submitted the response. Angle says it continues to anticipate a regulatory decision from US regulator during the second half of 2021.
Current stock price: 128.00 pence
Year-to-date change: more than doubled from 47.75p on December 31
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Angle (AGL)